62
70
Growth Score
-13 pts
Heat Score
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
428139
genOway develop the most adapted, highly physiologically relevant genetically modified rodent models for each research program.
- Alexandre Fraichard: CEO and Founder
About the Company
genOway is a biotechnology company that specializes in developing genetically modified research models with strong added value for the biopharmaceutical industries and academic researches. genOway is a leader in its market. It builds its development on the combination of a large and exclusive technological platform and a strong intellectual
property combining operating patents and licenses. genOway struck several commercial contracts with pharmaceutical industry leaders (Janssen R&D, GSK, Pfizer, etc.), and with the most prestigious academic research centers (King's College and Manchester in England, Harvard, Caltech and National Institute of Health in the United States, the Institut Pasteur in France, the NGFN, etc.).
